Entropic Labs SARM RAD-140 — Class II drug recall D-0800-2020
Terminated recall by Tuscano and Delucia Group (DBA Entropic Labs), reported 2020-01-29, distributed nationwide. Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs)
| Recall number | D-0800-2020 |
|---|---|
| Product type | Drug |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | Tuscano and Delucia Group (DBA Entropic Labs), Salt Lake City, UT, United States |
| Recall initiated | 2019-08-24 |
| Classified | 2020-01-22 |
| Reported by FDA | 2020-01-29 |
| Terminated | 2023-07-12 |
| Distributed | Nationwide (US) |
| Quantity | 60 |
| Reason classes | unapproved product |
| UPC / GTIN / UDI-DI | 00651074545302 |
Product
Entropic Labs SARM RAD-140, 20mg Capsules, 30-count bottles, Entropic Labs UPC#: 651074545302
Reason for recall
Marketed Without An Approved NDA/ANDA: product contains Selective Androgen Receptor Modulators (SARMs)
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0800-2020. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.